Navigation Links
RainDance Technologies to Present 'Sequence Enrichment Using Droplet-Based Microfluidics' Workshop at ASHG 2008
Date:11/3/2008

ore about RainDance Technologies and its revolutionary new RainStorm(TM) droplet-based microfluidic technology, visit booth 825 at ASHG 2008, or the company's website at http://www.raindancetech.com.

About RainDance Technologies, Inc.

RainDance Technologies, Inc. is a provider of innovative droplet-based microfluidic solutions for human health and disease research. The speed and simplicity of the company's exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company's technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimized process-induced bias or error.

RainDance's initial application will focus on the targeted resequencing of the human genome -- one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology.

RainDance was founded in 2004 by scientists from Harvard University; the Medical Research Centre in Cambridge, England and the ESPCI in Paris.

For more information, please visit http://www.raindancetech.com.


'/>"/>
SOURCE RainDance Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
2. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
3. RainDance Dedicates New Headquarters, Manufacturing Facility
4. RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
5. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
6. RainDance Technologies Appoints Olex Vice President, System Development
7. RainDance Appoints Kelly Chief Operating Officer
8. RainDance Announces Company Relocation and Manufacturing Startup
9. RainDance Appoints Becker Chief Commercial Officer
10. RainDance Technologies Appoints McNary President and CEO
11. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Myriant Technologies LLC ("Myriant"), a privately-...able bio-chemicals, Uhde Corporation of America an... of the world,s leading engineering contractors (j...neering, procurement & construction (EPC) of M...newable feedstocks. The execution of this allianc...
(Date:11/6/2009)...- Intarcia Therapeutics, Inc. delivered two presen...ous delivery of exenatide) program for the treatme... Technology Meeting in San Francisco, CA: ,, (L.../SFTU126LOGO ) ,, Continuous Subcutaneous Del...ose, HbA1c and Reduces Weight in a 28-day Phase 1b...
(Date:11/5/2009)...-- DSM Pharmaceutical Products today announced tha...x, Saint Jean D,Illac, France, where DSM will be t...r for Galenix commercial products on a global basi...ess development opportunities co-marketing Galenix... of Galenix in drug product development and clinic...
(Date:11/5/2009)...stCall/ -- BioSpecifics Technologies Corp. (Nasdaq...first-in-class collagenase-based products, today a...er ended September 30, 2009. ,, "We were extre...A,s Arthritis Advisory Committee unanimously recom...(TM) for the treatment of Dupuytren,s disease, and...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...r immune enhancement during cold & flu season, PU...utrition Reviews (Vol. 66(9):526-531) by Dr. Barry...nology at Drexel University, has shown,how AHCC im...ctious agents., The scientific review analyzed ou...of AHCC supplementation on immune response followi...
...pt. 24 Omeros Corporation, a,Seattle-based biopha...ment,of a $20 million debt facility with BlueCrest...llion term loan drawn by Omeros at closing and the...p to the remaining $15,million. Other terms were n...with increased financial flexibility,as we continu...
...nced Life Sciences,Holdings, Inc. (Nasdaq: ADLS )...rn Time on Wednesday, October 1, 2008 to provide a...nference Call Details, The conference call will b...bcast, visit the Investor Relations section of the...://www.advancedlifesciences.com . Alternatively,in...
Other Biology Technology:Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents 2Omeros and BlueCrest Announce $20 Million Debt Facility 2Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008 2
(Date:11/4/2009)...Call/ -- Quest Diagnostics Incorporated (NYSE: DG...sting, information and services, announced that fo...me from continuing operations rose to $192 million...r $0.81 per diluted share, for the third quarter o...d by a $0.03 per share charge associated with the ...
(Date:11/4/2009)...- GenVault Corporation, the leader in ambient temp..., medicine and identification, today announced tha...O, will be presenting at the BIOCOM Investor Confe...Jolla, CA. ,, During the presentation, Dr. Well...r with recent customer, technical and strategic de...
(Date:11/4/2009)... GenVault Corporation (Carlsbad, CA) today announc... Board of Directors. Dr. Brody, the Irwin Jacobs ...claimed physician-scientist and university leader....erved as president of The Johns Hopkins University...eering and the Institute of Medicine, and is renow...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Rice University researchers ask if biofuels will lead to a drink or drive 8827 1Rice University researchers ask if biofuels will lead to a drink or drive 8827 2Sinovac Completes Construction of H1N1 Virus Seed Bank 12626 1Sinovac Completes Construction of H1N1 Virus Seed Bank 12626 2Sinovac Completes Construction of H1N1 Virus Seed Bank 12626 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 1Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 2Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 4Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 5Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 6
...tudy led by Akiko Hata, PhD, of Tufts University S...rotein expressed in the heart, FHL2, inhibits the ...oth muscle cells (vSMCs), which line blood vessels...n diseases such as atherosclerosis or normal tissu...transition between a resting and proliferative sta...
... that affect blood pressure were recently identifi...ng 34,433 Europeans. The findings of the study, in..., are being presented today in the Web edition of ...or contributing cause of cardiovascular disorders....difficult to identify genes that affect blood pres...
...emical Society (ACS) Weekly PressPac from the Offi...r-reviewed journals and Chemical & Engineering Ne...American Chemical Society as the source for this i...s.org/portal/PublicWebSite/pressroom/presspacs/CTP...dvance toward producing biofuels without stressing...
Other Biology News:Comprehensive genetic study paves way for new blood-pressure medicines 2American Chemical Society's weekly PressPac -- May 6, 2009 2American Chemical Society's weekly PressPac -- May 6, 2009 3American Chemical Society's weekly PressPac -- May 6, 2009 4American Chemical Society's weekly PressPac -- May 6, 2009 5American Chemical Society's weekly PressPac -- May 6, 2009 6
...igned for easy transformation of the budding yeast...sful transformation simply by mixing a plasmid DNA...o complicated steps, such as centrifugation or cel...ell suited for high-throughput transformation of a...
... help promote genomics-based research with S. aure... aureus ORFmer set that contains PCR primers to am...rain1. In addition, primer pairs are included to a...315 strains of S. aureus. The ORFmer set contains ...
...s own microplate stacker system, offers fast and r...ost devices:, , Ultra Evolution , SAFIRE monochrom...ctraFluor Plus , LS Series of Laser Scanners , Pow...ion and separation systems, Connect offers researc...
...e increases your lab productivity and allows you t... compliance. Move ahead beyond traditional paper-b... networked data system. *Instruments supported: ..., XP, PR, SR, PG-S, PG, SG, AT, MT, UMT, AB-S, PB-...
Biology Products: